Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence.

Großhennig S, Schmidl SR, Schmeisky G, Busse J, Stülke J.

Infect Immun. 2013 Mar;81(3):896-904. doi: 10.1128/IAI.01212-12. Epub 2013 Jan 7.

2.

Glycerol metabolism and its implication in virulence in Mycoplasma.

Blötz C, Stülke J.

FEMS Microbiol Rev. 2017 Sep 1;41(5):640-652. doi: 10.1093/femsre/fux033. Review.

PMID:
28961963
3.

Glycerol metabolism is important for cytotoxicity of Mycoplasma pneumoniae.

Hames C, Halbedel S, Hoppert M, Frey J, Stülke J.

J Bacteriol. 2009 Feb;191(3):747-53. doi: 10.1128/JB.01103-08. Epub 2008 Nov 21.

4.

A trigger enzyme in Mycoplasma pneumoniae: impact of the glycerophosphodiesterase GlpQ on virulence and gene expression.

Schmidl SR, Otto A, Lluch-Senar M, Piñol J, Busse J, Becher D, Stülke J.

PLoS Pathog. 2011 Sep;7(9):e1002263. doi: 10.1371/journal.ppat.1002263. Epub 2011 Sep 22.

5.

Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.

Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, Krunkosky TM, Davis A, Hardy RD, Baseman JB.

Mol Microbiol. 2010 Jun 1;76(5):1127-41. doi: 10.1111/j.1365-2958.2010.07092.x. Epub 2010 Feb 28.

6.

Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors.

Lluch-Senar M, Cozzuto L, Cano J, Delgado J, Llórens-Rico V, Pereyre S, Bebear C, Serrano L.

PLoS One. 2015 Sep 3;10(9):e0137354. doi: 10.1371/journal.pone.0137354. eCollection 2015.

7.

Transcription in Mycoplasma pneumoniae: analysis of the promoters of the ackA and ldh genes.

Halbedel S, Eilers H, Jonas B, Busse J, Hecker M, Engelmann S, Stülke J.

J Mol Biol. 2007 Aug 17;371(3):596-607. Epub 2007 Jun 9.

PMID:
17586527
8.

The stability of cytadherence proteins in Mycoplasma pneumoniae requires activity of the protein kinase PrkC.

Schmidl SR, Gronau K, Hames C, Busse J, Becher D, Hecker M, Stülke J.

Infect Immun. 2010 Jan;78(1):184-92. doi: 10.1128/IAI.00958-09. Epub 2009 Oct 26.

9.

Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen.

Meseguer MA, Alvarez A, Rejas MT, Sánchez C, Pérez-Díaz JC, Baquero F.

Infect Genet Evol. 2003 May;3(1):47-55.

PMID:
12797972
10.

Regulation of carbon metabolism in the mollicutes and its relation to virulence.

Halbedel S, Hames C, Stülke J.

J Mol Microbiol Biotechnol. 2007;12(1-2):147-54. Review.

PMID:
17183222
11.

Pathogenesis of Mycoplasma pneumoniae: An update.

Chaudhry R, Ghosh A, Chandolia A.

Indian J Med Microbiol. 2016 Jan-Mar;34(1):7-16. doi: 10.4103/0255-0857.174112. Review.

12.

The changing pathogenicity of Mycoplasma pneumoniae with passage in vitro. Correlates of virulence.

Collier AM, Hu PC, Clyde WA Jr.

Diagn Microbiol Infect Dis. 1985 Jul;3(4):321-8. Review.

PMID:
2411465
13.

[The genetic view of Mycoplasma infections].

Kenri T.

Nihon Rinsho. 2003 Mar;61 Suppl 3:772-8. Review. Japanese. No abstract available.

PMID:
12718063
14.

Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells.

Yavlovich A, Tarshis M, Rottem S.

FEMS Microbiol Lett. 2004 Apr 15;233(2):241-6.

15.
16.
17.

Hydrogen peroxide production from glycerol metabolism is dispensable for virulence of Mycoplasma gallisepticum in the tracheas of chickens.

Szczepanek SM, Boccaccio M, Pflaum K, Liao X, Geary SJ.

Infect Immun. 2014 Dec;82(12):4915-20. doi: 10.1128/IAI.02208-14. Epub 2014 Aug 25.

18.

Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae.

Kannan TR, Provenzano D, Wright JR, Baseman JB.

Infect Immun. 2005 May;73(5):2828-34.

19.

Loss of HMW1 and HMW3 in noncytadhering mutants of Mycoplasma pneumoniae occurs post-translationally.

Popham PL, Hahn TW, Krebes KA, Krause DC.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13979-84.

20.

Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, Coalson JJ, Baseman JB, Hardy RD.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):797-804. doi: 10.1164/rccm.201001-0080OC. Epub 2010 May 27.

Supplemental Content

Support Center